Baidu clarifies rumors of Kunlun chip separation and listing: Evaluation is ongoing, but no conclusion has been reached yet.
Baidu Group-SW (09888) announced that the company has noticed media reports on December 5, 2025, stating that the company plans to spin off its non-wholly owned subsidiary Kunlunxin (Beijing) Technology Co., Ltd. for independent listing. The company hereby clarifies that it is currently evaluating the proposed spin-off and listing. If the proposed spin-off and listing proceed, it will require regulatory approval and the company does not guarantee that the proposed spin-off and listing will be carried out.
BIDU-SW (09888) has issued an announcement, stating that the company noted media reports on December 5, 2025, regarding the company's plan to spin off its non-wholly-owned subsidiary Kunlunxin (Beijing) Technology Co., Ltd. for an independent listing. The company hereby clarifies that it is currently evaluating the proposed spin-off and listing. If the proposed spin-off and listing are to proceed, it will be subject to regulatory approval processes, and the company does not guarantee that the proposed spin-off and listing will take place.
Related Articles
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.
CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.
GMTEight List of A-share restricted sales and lifting restrictions | December 8th
Jiangsu Hengrui Pharmaceuticals (01276) has adjusted 20 products/indications to the new national medical insurance list. Among them, 10 products are included for the first time.
CHINA BOTON (03318) will be suspended from trading starting December 8th for a short period, awaiting the announcement of a significant sale transaction.
GMTEight List of A-share restricted sales and lifting restrictions | December 8th
